Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02811250 : Stereotactic Radiotherapy for Renal Cancers
PhasePhase 1
AgesMin: 75 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patient aged over 75 years with an operable renal tumor or patient with inoperable
renal tumor irrespective of age, or patient with metastatic renal tumor and
indication for nephrectomy.

- Histologically-confirmed Renal carcinoma less than or equal to 4 cm

- Tumor that is visible and measureable on abdominal scanner and/or MRI (Magnetic
Resonance Imaging)

- Karnofsky performance status ? 60%

Exclusion Criteria:

- Patient with only one kidney and renal cancer

- Patient not able to cooperate during treatment

- Previous history of abdominal radiation therapy

- Tumor having infiltrated the renal pelvis

- Polycystic kidney disease

- Previous history of intestinal inflammatory disease such as ulcerative colitis or
Crohn's disease

- Renal insufficiency (creatinine clearance <30 ml/mm evaluated by DTPA
(diethylenetriamine pentaacetic acid ) scintigraphy)

- Uncontrolled hypertension (SBP(systolic blood pressure) above 160 mmHg DBP(diastolic
blood pressure) above 100 mmHg with antihypertensive treatment)

- Non primary lesions (benign lesions such as angiomyolipoma, renal metastases,…)

- Antineoplastic and/or antiangiogenic treatment in the month preceding radiotherapy

- Progressive cancer other than renal cancer at time of inclusion with the exception of
in situ cervical carcinomas, basal cell carcinoma of the skin, and non-metastatic
prostate cancer controlled without hormone therapy

- Participation in another ongoing study that may interfere with the present study
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02811250      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740